CASI Pharmaceuticals Reaches Analyst Target Price

In recent trading, shares of CASI Pharmaceuticals, Inc. (CASI) have crossed above the average analyst 12-month target price of $3.50, changing hands for $3.64/share..
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.